Tempus, a precision medicine company, raised $100 million in Series G financing round at a post-money valuation of $5 billion. Investors include: The investors include
Tempus, a precision medicine company, raised $100 million in Series G financing round at a post-money valuation of $5 billion. Investors include: The investors include